Clinical Trial Update: Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

View source ↗

Summary

Clinical trial update on the prevalence of primary aldosteronism in patients with resistant hypertension in China; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Resistant Hypertension

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Hypertension, Resistant to Conventional Therapy | Status: COMPLETED